QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
27.90
+2.24 (8.73%)
At close: Aug 22, 2025, 4:00 PM
27.36
-0.54 (-1.94%)
After-hours: Aug 22, 2025, 4:36 PM EDT
QuidelOrtho Market Cap
QuidelOrtho has a market cap or net worth of $1.89 billion as of August 22, 2025. Its market cap has decreased by -28.83% in one year.
Market Cap
1.89B
Enterprise Value
4.54B
1-Year Change
-28.83%
Ranking
Category
Stock Price
$27.90
Market Cap Chart
Since December 1, 1998, QuidelOrtho's market cap has increased from $50.50M to $1.89B, an increase of 3,651.33%. That is a compound annual growth rate of 14.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 1.89B | -36.78% |
Dec 31, 2024 | 3.00B | -39.16% |
Dec 29, 2023 | 4.92B | -12.97% |
Dec 30, 2022 | 5.66B | 0.58% |
Dec 31, 2021 | 5.63B | -25.56% |
Dec 31, 2020 | 7.56B | 141.82% |
Dec 31, 2019 | 3.13B | 62.74% |
Dec 31, 2018 | 1.92B | 30.30% |
Dec 29, 2017 | 1.47B | 110.78% |
Dec 30, 2016 | 699.20M | -0.82% |
Dec 31, 2015 | 705.00M | -29.16% |
Dec 31, 2014 | 995.20M | -5.10% |
Dec 31, 2013 | 1.05B | 69.58% |
Dec 31, 2012 | 618.40M | 22.92% |
Dec 30, 2011 | 503.10M | 22.14% |
Dec 31, 2010 | 411.90M | -0.84% |
Dec 31, 2009 | 415.40M | -2.35% |
Dec 31, 2008 | 425.40M | -33.14% |
Dec 31, 2007 | 636.30M | 39.94% |
Dec 29, 2006 | 454.70M | 28.37% |
Dec 30, 2005 | 354.20M | 120.00% |
Dec 31, 2004 | 161.00M | -48.86% |
Dec 31, 2003 | 314.80M | 214.17% |
Dec 31, 2002 | 100.20M | -54.14% |
Dec 31, 2001 | 218.50M | 74.94% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 638.90B |
Johnson & Johnson | 431.79B |
AbbVie | 372.04B |
UnitedHealth Group | 278.42B |
Novo Nordisk | 253.97B |
AstraZeneca | 251.25B |
Novartis AG | 246.51B |
Abbott Laboratories | 230.77B |